SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001432
Filing Date
2019-03-01
Accepted
2019-03-01 16:42:34
Documents
89
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imgn-20181231x10k.htm 10-K 4040037
2 EX-10.1(K) imgn-20181231ex101kcc570.htm EX-10.1(K) 30813
3 EX-10.13 imgn-20181231ex10133912a.htm EX-10.13 531360
4 EX-21 imgn-20181231ex218e9757e.htm EX-21 8536
5 EX-23 imgn-20181231xex23.htm EX-23 3742
6 EX-31.1 imgn-20181231ex3114ee77c.htm EX-31.1 21013
7 EX-32 imgn-20181231xex32.htm EX-32 10830
  Complete submission text file 0001558370-19-001432.txt   18788050

Data Files

Seq Description Document Type Size
8 EX-101.INS imgn-20181231.xml EX-101.INS 4721636
9 EX-101.SCH imgn-20181231.xsd EX-101.SCH 76453
10 EX-101.CAL imgn-20181231_cal.xml EX-101.CAL 64187
11 EX-101.DEF imgn-20181231_def.xml EX-101.DEF 486320
12 EX-101.LAB imgn-20181231_lab.xml EX-101.LAB 715328
13 EX-101.PRE imgn-20181231_pre.xml EX-101.PRE 731871
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17999 | Film No.: 19650101
SIC: 2834 Pharmaceutical Preparations